B
BioVentrix
United States · Healthtech
BioVentrix develops medical devices for cardiac remodeling in patients with heart failure caused by damage to the left ventricle.
Product
Its Revivent System is designed to reshape the damaged left ventricle through a less invasive procedure. The company is headquartered in Mansfield, Massachusetts.
Clinical development
The RELIVE randomized trial compares the Revivent procedure plus guideline directed medical therapy with medical therapy alone. Revivent remains investigational in the United States.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Debt and warrant offering | $1.2M | Participants not disclosed |